RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Capital expenditures

INSMED IncINSM

Market cap
$41.3B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-22+64.98%
Dec 31, 2023-13+34.52%
Dec 31, 2022-10+35.52%
Dec 31, 2021-7+16.81%
Dec 31, 2020-6-85.24%
Dec 31, 2019-42+222.90%
Dec 31, 2018-13+336.19%
Dec 31, 2017-3-28.55%
Dec 31, 2016-4+21.60%
Dec 31, 2015-3-35.45%
Dec 31, 2014-5+547.82%
Dec 31, 2013-1+184.83%
Dec 31, 2012-0-70.38%
Dec 31, 2011-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)